Data / Form D filings / RESPONSE BIOMEDICAL CORP
RESPONSE BIOMEDICAL CORP: Form D filings
RESPONSE BIOMEDICAL CORP, a health care company in Vancouver, British Columbia, Canada, filed 6 Form D notices with the SEC between 2009 and 2013. The latest, on October 15, 2013, reports $3.1 million sold of a $4 million offering to 10 investors.
Find out what RESPONSE BIOMEDICAL CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1781 - 75TH AVENUE W., Vancouver, British Columbia, Canada, V6P6P
- Phone
- (604) 456-6010
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 806888
The full lists. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2013 | New notice | $4,000,000 | $3,119,136 | $880,864 | 10 | Sep 26, 2013 | sec.gov |
| Jan 6, 2012 | New notice | $4,937,100 | $4,937,100 | $0 | 7 | Dec 30, 2011 | sec.gov |
| Dec 1, 2011 | New notice | $1,929,000 | $265,238 | $1,663,762 | 3 | Nov 22, 2011 | sec.gov |
| Aug 12, 2010 | New notice | $7,724,990 | $7,724,990 | $0 | 3 | Jul 28, 2010 | sec.gov |
| May 25, 2010 | New notice | $102,137 | $0 | $102,137 | 0 | Yet to occur | sec.gov |
| May 29, 2009 | New notice | $7,184,331 | $3,918,726 | $3,265,605 | 12 | May 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David A. Wang | Director | |
| Clinton H. Severson | Director | |
| Anthony F. Holler | Director | |
| Jeffrey L. Purvin | Executive Officer, Director | |
| Lewis H. Shuster | Director | |
| William J. Adams | Executive Officer | |
| Joseph D. Keegan | Director | |
| Peter A. Thompson | Director |
Every Form D from the week of Oct 14, 2013 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what RESPONSE BIOMEDICAL CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.